BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11891465)

  • 1. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
    Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
    Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
    Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
    Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of brain tumour imaging with p-[123I]iodo-L-phenylalanine and SPECT.
    Hellwig D; Ketter R; Romeike BF; Sell N; Schaefer A; Moringlane JR; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1041-9. PubMed ID: 15902439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
    Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M; Stevens H; Taphoorn M; Van Rijk P
    Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
    Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
    Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
    Hellwig D; Gouverneur E; Schaefer A; Raedle J; Menges M; Kirsch CM; Samnick S
    Nuklearmedizin; 2008; 47(5):220-4. PubMed ID: 18852930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
    Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells.
    Samnick S; Schaefer A; Siebert S; Richter S; Vollmar B; Kirsch CM
    Nucl Med Biol; 2001 Jan; 28(1):13-23. PubMed ID: 11182560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
    Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
    Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the cardiac sympathetic nervous system by single photon emission tomography with technetium-99m-labelled fluorobenzylpiperidine derivative (99mTc-FBPBAT): result of a feasibility study in a porcine model and an initial dosimetric estimation in humans.
    Richter S; Schaefer A; Menger MD; Kirsch CM; Samnick S
    Nucl Med Commun; 2005 Apr; 26(4):361-8. PubMed ID: 15753796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma.
    Hellwig D; Ketter R; Romeike BF; Schaefer A; Farmakis G; Grgic A; Moringlane JR; Steudel WI; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2344-53. PubMed ID: 20676638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
    Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
    Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.
    Soler C; Beauchesne P; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
    Eur J Nucl Med; 1998 Dec; 25(12):1649-57. PubMed ID: 9871097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
    Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
    Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.